Symbol not found

:MYOV 00:00AM GMT

0.00

0.00 (0.00%)

Market Cap (Intraday)	NA
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$244.82 Million
Adjusted EPS	$0.56

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Myovant Sciences Ltd Stock, :MYOV

11-12 St. JamesÃ¢â?¬â?¢s Square, Suite 1, 3rd Floor, London, Greater London SW1Y 4LB

Bermuda

Phone: +44.207.400.3351

Number of Employees: 579

http://www.myovant.com

Description

Myovant Sciences is a biotech company that develops new treatments for infertility in women and prostate cancer in men. The company's product capabilities and help continue to deliver innovative therapies addressing unmet patient needs in prostate cancer and womenÃ¢â?¬â?¢s health. Myovant Sciences was established in 2016 and is based in Brisbane, California.